Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Hyperthyroidism can hide signs of high androgen levels in females.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.